CS logo
small CS logo
UPMC Department of Dermatology

Pittsburgh, Pennsylvania, United States
University department in Pittsburgh, Pennsylvania
3708 Fifth Ave #5th, Pittsburgh, PA 15213

About UPMC Department of Dermatology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
LEO Pharma
2
Aristea Therapeutics, Inc.
1
Bristol-Myers Squibb
1
Novartis Pharmaceuticals
1
Prothena Biosciences Limited
1
University of Pittsburgh
1
Total Rows: 7

Clinical Trials at UPMC Department of Dermatology


During the past decade, UPMC Department of Dermatology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2222000011002200111100221100Started TrialsCompleted Trails20162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Immunization Against Tumor Cells in Sezary Syndrome
2004-09-01
2007-09-01
Completed
17
Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
2007-01-01
2013-06-01
Completed
139
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
2010-09-01
2016-06-01
Terminated
2,867
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
2011-03-01
2013-04-01
Completed
901
Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis
2016-03-17
2018-02-28
Completed
48
Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis
2016-04-01
2017-04-01
Completed
269
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
2017-02-15
2019-06-26
Completed
722
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
2017-05-30
2019-10-10
Completed
802

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "UPMC Department of Dermatology" #1 sponsor was "Pfizer" with 4 trials, followed by "LEO Pharma" with 2 trials sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Department of Dermatology" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4LEO Pharma: 2LEO Pharma: 2Aristea Therapeutics, Inc.: 1Aristea Therapeutics, Inc.: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1Prothena Biosciences Limited: 1Prothena Biosciences Limited: 1University of Pittsburgh: 1University of Pittsburgh: 1

Created with Highcharts 11.1.0Top CollaboratorsArena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1

Clinical Trials Conditions at UPMC Department of Dermatology


According to Clinical.Site data, the most researched conditions in "UPMC Department of Dermatology" are "Psoriasis" (4 trials), "Atopic Dermatitis" (2 trials), "Alopecia Areata" (1 trials), "Cutaneous T-Cell Lymphoma" (1 trials) and "Cutaneous T-cell Lymphoma" (1 trials). Many other conditions were trialed in "UPMC Department of Dermatology" in a lesser frequency.

Clinical Trials Intervention Types at UPMC Department of Dermatology


Most popular intervention types in "UPMC Department of Dermatology" are "Drug" (10 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "CP-690,550" (2 trials), "Autologous Dendritic Cell Vaccine" (1 trials), "Deucravacitinib" (1 trials) and "Etrasimod" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UPMC Department of Dermatology


The vast majority of trials in "UPMC Department of Dermatology" are 11 trials for "All" genders.

Clinical Trials Status at UPMC Department of Dermatology


Currently, there are NaN active trials in "UPMC Department of Dermatology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in UPMC Department of Dermatology, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Department of Dermatology, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 5Phase 2: 5Phase 3: 4Phase 3: 4Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Terminated: 2Terminated: 2Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1